查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2032401

心血管植入市場報告：按產品類型、材料、手術、適應症和地區分類（2026-2034 年）

Cardiovascular Implants Market Report by Product Type, Material, Procedure Type, Indication, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 139 Pages | 商品交期: 2-3個工作天內

價格

2025年全球心血管植入市場規模達290億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到465億美元，2026年至2034年的複合年成長率為5.22%。心血管疾病盛行率上升、人口老化以及醫療領域的重大進步是推動市場成長的主要因素。

心血管植入市場趨勢：

心血管疾病盛行率不斷上升

隨著冠狀動脈疾病、心臟衰竭和心律不整等心血管疾病在全球範圍內持續成長，對用於有效管理和治療這些疾病的心血管植入的需求也日益增加。例如，根據美國疾病管制與預防中心 (CDC) 2024 年發表的一篇報導，每 33 秒就有一人死於心血管疾病。 2022 年，約有 702,800 人（即五分之一的人口）死於心臟病。此外，冠狀動脈疾病是最常見的心臟病，影響大約每 20 人中就有 1 人患有此病。預計這些因素將在未來幾年推動心血管植入市場的發展。

人口老化的過程

人口老化是心血管植入市場的主要驅動力。例如，世界衛生組織（WHO）發表的報導預測，到2030年，全球六分之一的人口將超過60歲。目前，60歲及以上人口的比例已從2020年的10億增加到14億。預計到2050年，全球60歲以上人口將翻倍，達到21億人。隨著人口老化，心血管疾病的發生率增加，因此需要心律調節器、去心房顫動和人工心臟瓣膜等治療性介入。例如，根據Medline Plus發表的報導顯示，75歲及以上人群發生鬱血性心臟衰竭的機率是年輕人的10倍。這些因素進一步推動了心血管植入市場佔有率的成長。

技術進步

心血管植入技術的持續創新正在推動市場成長。這些進步包括生物可吸收支架、經導管主動脈瓣置換術(TAVR)、無導線心律調節器和植入式心臟監測器，它們顯著提高了療效、耐用性和患者預後。例如，2024 年 5 月，愛德華生命科學公司在歐洲推出了 Sapien 3 Ultra Resilia 瓣膜。本產品採用牛心包組織，並經抗鈣化技術處理，實現了新型瓣膜的研發。這種鈣化密封技術有效解決了瓣膜結構劣化問題，而瓣膜結構退化是瓣膜置換術再次手術的主要原因之一，從而提升了心血管植入系統的市場收入。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球心血管植入市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場區隔：依產品類型
  • 市場區隔：依材料分類
  • 市場區隔：依手術類型
  • 市場區隔：依指標
  • 市場區隔：按地區
  • 市場預測

第6章 市場區隔：依產品類型分類

  • 冠狀動脈支架
  • ICD
  • 心臟瓣膜
  • 植入式心臟節律器
  • CRT裝置
  • 末梢用支架

第7章 市場區隔：依材料分類

  • 金屬和合金
  • 聚合物
  • 生物來源材料

第8章 市場區隔：依手術類型分類

  • 血管成形術
  • 開胸手術

第9章 市場區隔：依適應症分類

  • 心律不整
  • 心肌缺血
  • 急性心肌梗塞
  • 鬱血性心臟衰竭
  • 其他

第10章 市場區隔：依地區分類

  • 北美洲
  • 歐洲
  • 亞太地區
  • 中東和非洲
  • 拉丁美洲

第11章 SWOT 分析

第12章：價值鏈分析

第13章：波特五力分析

第14章：價格分析

第15章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • BIOTRONIK SE & Co. KG
    • Abbott Laboratories
    • AMG International
    • B. Braun Melsungen AG
    • Johnson & Johnson Services, Inc.
    • WL Gore & Associates, Inc.
    • Medtronic Private Limited
    • Boston Scientific Corporation
    • Sorin Corporation
    • Edwards Lifesciences Corporation
    • Fortimedix Surgical BV
    • Neovasc Inc.
    • CryoLife Inc.
    • Proxy Biomedical Ltd.
    • REVA Medical, LLC.
    • Shree Pacetronix Ltd.
Product Code: SR112026A1164

The global cardiovascular implants market size reached USD 29.0 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 46.5 Billion by 2034, exhibiting a growth rate (CAGR) of 5.22% during 2026-2034. The rising prevalence of cardiovascular diseases, the expanding geriatric population, and significant advancements in the healthcare sector, represent some of the key factors driving the market.

CARDIOVASCULAR IMPLANTS MARKET ANALYSIS:

  • Major Market Drivers: The increasing incidences of CVDs due to sedentary lifestyles, unhealthy dietary habits, high-stress levels, and the expanding prevalence of diabetes and obesity among consumers, represent key factors driving the market growth. Moreover, the rising geriatric population who are more susceptible to medical conditions, coupled with significant advancements in healthcare infrastructure, is creating a favorable outlook for the market.
  • Key Market Trends: The shifting preference for minimally invasive surgeries (MIS) due to their associated benefits, such as faster recovery and improved patient outcomes, presents remunerative growth opportunities for the market. In addition, ongoing advancements in technology, introduction of sophisticated cardiovascular implants, and extensive investments in research and development (R&D) initiatives by leading market players to develop improved product variants, are contributing to the market growth.
  • Competitive Landscape: Some of the prominent cardiovascular implants market companies include BIOTRONIK SE & Co. KG, Abbott Laboratories, AMG International, B. Braun Melsungen AG, Johnson & Johnson Services, Inc., W. L. Gore & Associates, Inc., Medtronic Private Limited, Boston Scientific Corporation, Sorin Corporation, Edwards Lifesciences Corporation, Fortimedix Surgical B.V., Neovasc Inc., CryoLife Inc., Proxy Biomedical Ltd., REVA Medical, LLC., and Shree Pacetronix Ltd., among many others.
  • Geographical Trends: According to the cardiovascular implants market dynamics, North America exhibits a clear dominance in the market owing to a significant burden of cardiovascular diseases (CVDs), such as coronary artery disease, hypertension, and heart failure.
  • Challenges and Opportunities: Stringent regulatory compliances and high costs associated with cardiovascular implants. Moreover, advances in materials science, nanotechnology, and biocompatibility are driving the development of next-generation cardiovascular implants with improved performance and safety profiles.

CARDIOVASCULAR IMPLANTS MARKET TRENDS:

Rising Prevalence of Cardiovascular Diseases

As cardiovascular diseases, such as coronary artery disease, heart failure, and arrhythmias, continue to rise globally, there is a growing demand for cardiovascular implants to manage and treat these conditions effectively. For instance, according to an article published by the U.S. Centers for Disease Control and Prevention in 2024, one person dies every 33 seconds from cardiovascular disease. Also, in 2022 nearly 702,800 i.e., one in five people died from heart disease. Moreover, coronary heart disease is the most prevalent form of heart disease. About one in every twenty individuals aged 20 and older has CAD. These factors are expected to propel the cardiovascular implants market in the coming years.

Increasing Aging Population

The demographic shift towards an older population is a major driver of the cardiovascular implant market. For instance, according to an article published by the World Health Organization (WHO), by 2030, one in every six persons in the world will be 60 or older. At this time, the proportion of the population aged 60 and up rose from 1 billion in 2020 to 1.4 billion. By 2050, the global population of persons aged 60 and up will double (2.1 billion). Aging is associated with a higher incidence of cardiovascular diseases, necessitating interventions, such as pacemakers, defibrillators, and heart valves. For instance, according to an article published by Medline Plus, congestive heart failure affects people over the age of 75 at ten times the rate of younger adults. These factors further positively influence the cardiovascular implants market share.

Technological Advancements

Continuous innovations in cardiovascular implant technologies drive the market growth. Advances include bioresorbable stents, transcatheter heart valves (TAVR), leadless pacemakers, and implantable cardiac monitors, which offer improved efficacy, durability, and patient outcomes. For instance, in May 2024, Edwards Lifesciences launched the Sapien 3 Ultra Resilia valve in Europe. It uses bovine pericardial tissue treated with anti-calcification technology to serve as the foundation for new types of valves. The calcium-blocking method addresses structural valve degradation, which is a leading cause of reintervention following valve replacement, thereby boosting the cardiovascular implant systems market revenue.

GLOBAL CARDIOVASCULAR IMPLANTS INDUSTRY SEGMENTATION:

Breakup by Product Type:

  • Coronary Stent
  • ICD
  • Heart Valve
  • Implanted Cardiac Pacemaker
  • CRT Device
  • Peripheral Stent

ICD currently exhibits a clear dominance in the market

ICDs are crucial in preventing sudden cardiac death (SCD) by detecting and correcting life-threatening arrhythmias, such as ventricular tachycardia and ventricular fibrillation. This life-saving capability positions ICDs as essential devices for patients at high risk of cardiac arrhythmias. For instance, in October 2023, Medtronic plc, a global healthcare technology provider, received U.S. FDA approval for the Aurora EV-ICD MRI SureScan.

Breakup by Material:

  • Metals and Alloys
  • Polymers
  • Biological Materials

According to the cardiovascular implants market overview, metals and alloys are used in stents due to their mechanical strength, corrosion resistance, and ability to be manufactured into intricate designs. Moreover, polymers are used in pacemaker and defibrillator leads for insulation, flexibility, and biocompatibility. Apart from this, biological materials are used in bioprosthetic heart valves, where animal (porcine or bovine) or human tissue (cadaveric) is used for valve leaflets. These valves offer improved hemodynamics and reduced risk of thrombosis compared to mechanical valves.

Breakup by Procedure Type:

  • Angioplasty
  • Open Heart Surgery

Angioplasty is a minimally invasive procedure used to widen narrowed or blocked arteries typically caused by atherosclerosis. It involves the use of a catheter with a balloon at its tip, which is inflated at the site of the blockage to compress the plaque against the artery walls, thereby restoring blood flow. Moreover, open-heart surgery is a surgical procedure where the chest is opened to access the heart. It is used for a variety of conditions, including coronary artery bypass grafting (CABG), valve repair or replacement, and congenital heart defect repairs.

Breakup by Indication:

  • Arrhythmias
  • Myocardial Ischemia
  • Acute Myocardial Infarction
  • Congestive Heart Failure
  • Others

Arrhythmias accounted for the largest market share

Arrhythmias are common cardiac disorders affecting millions of people worldwide. They include conditions such as atrial fibrillation (AFib), ventricular tachycardia (VT), and bradyarrhythmias (slow heart rhythms). The high prevalence of these conditions necessitates a wide array of implantable devices for management and treatment.

Breakup by Region:

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

North America accounts for the largest market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. According to the report, North America was the largest market for cardiovascular implants.

Some of the factors driving the North America cardiovascular implants market included the rising prevalence of CVDs, innovative product advancements, and the growing geriatric population. The region has a significant burden of cardiovascular diseases, such as coronary artery disease, hypertension, and heart failure. For instance, according to the Centers for Disease Control and Prevention's (CDC) updated report for 2022, the number of fatalities in the United States from heart disease was 659,041 in 2019 and grew to nearly 690,882 by 2020. The high prevalence of these conditions necessitates a range of cardiovascular implants for treatment and management. Moreover, continuous innovations in cardiovascular implant technologies, including stents, pacemakers, implantable defibrillators, and heart valves, drive the market growth. Advances such as bioresorbable stents, leadless pacemakers, and transcatheter heart valves (TAVR) improve patient outcomes and expand treatment options.

COMPETITIVE LANDSCAPE:

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major market companies have also been provided. Some of the key players in the market include:

  • BIOTRONIK SE & Co. KG
  • Abbott Laboratories
  • AMG International
  • B. Braun Melsungen AG
  • Johnson & Johnson Services, Inc.
  • W. L. Gore & Associates, Inc.
  • Medtronic Private Limited
  • Boston Scientific Corporation
  • Sorin Corporation
  • Edwards Lifesciences Corporation
  • Fortimedix Surgical B.V.
  • Neovasc Inc.
  • CryoLife Inc.
  • Proxy Biomedical Ltd.
  • REVA Medical, LLC.
  • Shree Pacetronix Ltd.

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Cardiovascular Implants Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Product Type
  • 5.5 Market Breakup by Material
  • 5.6 Market Breakup by Procedure Type
  • 5.7 Market Breakup by Indication
  • 5.8 Market Breakup by Region
  • 5.9 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Coronary Stent
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 ICD
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Heart Valve
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Implanted Cardiac Pacemaker
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 CRT Device
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Peripheral Stent
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Material

  • 7.1 Metals and Alloys
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Polymers
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Biological Materials
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Procedure Type

  • 8.1 Angioplasty
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Open Heart Surgery
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Indication

  • 9.1 Arrhythmias
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Myocardial Ischemia
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Acute Myocardial Infarction
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Congestive Heart Failure
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Others
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Europe
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Asia Pacific
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Middle East and Africa
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast
  • 10.5 Latin America
    • 10.5.1 Market Trends
    • 10.5.2 Market Forecast

11 Global Cardiovascular Implants Industry: SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Global Cardiovascular Implants Industry: Value Chain Analysis

13 Global Cardiovascular Implants Industry: Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Global Cardiovascular Implants Industry: Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 BIOTRONIK SE & Co. KG
    • 15.3.2 Abbott Laboratories
    • 15.3.3 AMG International
    • 15.3.4 B. Braun Melsungen AG
    • 15.3.5 Johnson & Johnson Services, Inc.
    • 15.3.6 W. L. Gore & Associates, Inc.
    • 15.3.7 Medtronic Private Limited
    • 15.3.8 Boston Scientific Corporation
    • 15.3.9 Sorin Corporation
    • 15.3.10 Edwards Lifesciences Corporation
    • 15.3.11 Fortimedix Surgical B.V.
    • 15.3.12 Neovasc Inc.
    • 15.3.13 CryoLife Inc.
    • 15.3.14 Proxy Biomedical Ltd.
    • 15.3.15 REVA Medical, LLC.
    • 15.3.16 Shree Pacetronix Ltd.

List of Figures

  • Figure 1: Global: Cardiovascular Implants Market: Major Drivers and Challenges
  • Figure 2: Global: Cardiovascular Implants Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Cardiovascular Implants Market: Breakup by Product Type (in %), 2025
  • Figure 4: Global: Cardiovascular Implants Market: Breakup by Material (in %), 2025
  • Figure 5: Global: Cardiovascular Implants Market: Breakup by Procedure Type (in %), 2025
  • Figure 6: Global: Cardiovascular Implants Market: Breakup by Indication (in %), 2025
  • Figure 7: Global: Cardiovascular Implants Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Cardiovascular Implants Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 9: Global: Cardiovascular Implants Industry: SWOT Analysis
  • Figure 10: Global: Cardiovascular Implants Industry: Value Chain Analysis
  • Figure 11: Global: Cardiovascular Implants Industry: Porter's Five Forces Analysis
  • Figure 12: Global: Cardiovascular Implants (Coronary Stent) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Cardiovascular Implants (Coronary Stent) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Cardiovascular Implants (ICD) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Cardiovascular Implants (ICD) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Cardiovascular Implants (Heart Valve) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Cardiovascular Implants (Heart Valve) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Cardiovascular Implants (Implanted Cardiac Pacemaker) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Cardiovascular Implants (Implanted Cardiac Pacemaker) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Cardiovascular Implants (CRT Device) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Cardiovascular Implants (CRT Device) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Cardiovascular Implants (Peripheral Stent) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Cardiovascular Implants (Peripheral Stent) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Cardiovascular Implants (Metals and Alloys) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Cardiovascular Implants (Metals and Alloys) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Cardiovascular Implants (Polymers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Cardiovascular Implants (Polymers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Global: Cardiovascular Implants (Biological Materials) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Global: Cardiovascular Implants (Biological Materials) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Global: Cardiovascular Implants (Angioplasty) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Global: Cardiovascular Implants (Angioplasty) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: Global: Cardiovascular Implants (Open Heart Surgery) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: Global: Cardiovascular Implants (Open Heart Surgery) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Global: Cardiovascular Implants (Arrhythmias) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Global: Cardiovascular Implants (Arrhythmias) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: Global: Cardiovascular Implants (Myocardial Ischemia) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: Global: Cardiovascular Implants (Myocardial Ischemia) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: Global: Cardiovascular Implants (Acute Myocardial Infarction) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: Global: Cardiovascular Implants (Acute Myocardial Infarction) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: Global: Cardiovascular Implants (Congestive Heart Failure) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: Global: Cardiovascular Implants (Congestive Heart Failure) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: Global: Cardiovascular Implants (Other Indications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: Global: Cardiovascular Implants (Other Indications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: North America: Cardiovascular Implants Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: North America: Cardiovascular Implants Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Europe: Cardiovascular Implants Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Europe: Cardiovascular Implants Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Asia Pacific: Cardiovascular Implants Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Asia Pacific: Cardiovascular Implants Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: Middle East and Africa: Cardiovascular Implants Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: Middle East and Africa: Cardiovascular Implants Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: Latin America: Cardiovascular Implants Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: Latin America: Cardiovascular Implants Market Forecast: Sales Value (in Million USD), 2026-2034

List of Tables

  • Table 1: Global: Cardiovascular Implants Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Cardiovascular Implants Market Forecast: Breakup by Product Type (in Million USD), 2026-2034
  • Table 3: Global: Cardiovascular Implants Market Forecast: Breakup by Material (in Million USD), 2026-2034
  • Table 4: Global: Cardiovascular Implants Market Forecast: Breakup by Procedure Type (in Million USD), 2026-2034
  • Table 5: Global: Cardiovascular Implants Market Forecast: Breakup by Indication (in Million USD), 2026-2034
  • Table 6: Global: Cardiovascular Implants Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 7: Global: Cardiovascular Implants Market Structure
  • Table 8: Global: Cardiovascular Implants Market: Key Players